5cladb Applications: Neuroprotection in ALS, Chronic Pelvic Pain Relief, and CLAD Prevention Post-Lung Transplant
As a selective CB2 cannabinoid receptor agonist, 5cladb (5-Chloro-ADB-A) is expanding its therapeutic footprint into devastating, underserved conditions—including neurodegenerative diseases like amyotrophic lateral sclerosis (ALS), chronic pelvic pain (CPP) in women, and post-lung transplant complications. Its unique ability to target peripheral inflammation, protect vulnerable cells, and avoid psychoactive effects positions it as a transformative tool